Compare ex vivo human skin models

Find the right human skin model for your research.

Genoskin offers a range of ex vivo human skin models designed for different research needs, from topical testing to injectable drug efficacy assessment, wound healing and site-specific applications. Use the table below to compare their main features, formats and applications.

Biological platforms adapted to your research needs.

HypoSkin Human skin model for injectable testing

HypoSkin®


Human skin model for injectable testing

HypoSkin® is a live, full-thickness human skin model with epidermis, dermis and hypodermis. It supports intradermal and subcutaneous administration to assess the performance of injectable therapeutics and medical devices, injection site reactions, and local tolerance.

NativeSkin® Versatile ex vivo human skin model

NativeSkin®


Versatile ex vivo human skin model

NativeSkin® is a live, full-thickness human skin model preserving the epidermis, dermis, resident immune cells and skin appendages. It supports topical and systemic testing for efficacy, local safety, penetration, barrier function and inflammatory responses.

WoundSkin Ex vivo human wound model

WoundSkin®


Ex vivo human wound model

WoundSkin® is a live human skin model with a standardized wound surrounded by an intact epidermal, dermal and immune environment. It supports the evaluation of wound healing, infection, biofilm formation, and the efficacy of wound-care products and treatments.

HairSkin Ex vivo human scalp & hair follicle model

HairSkin®


Ex vivo human scalp & hair follicle model

HairSkin® is a live human skin model containing mature hair follicles and pilosebaceous units within their native environment. It supports scalp research, scalp-care and treatment development, follicular delivery, and haircare product evaluation.

FacialSkin Ex vivo human facial skin model

FacialSkin


Ex vivo human facial skin model

FacialSkin is a live human skin model derived from facial tissue that preserves its native epidermal and dermal architecture. It supports facial skincare research, anti-aging and treatment development, barrier assessment, and product efficacy and safety testing.

BreastSkin Ex vivo human breast skin model

BreastSkin


Ex vivo human breast skin model

BreastSkin is a live, full-thickness human skin model derived from breast tissue that preserves its native epidermal and dermal architecture. It supports breast, bust and décolleté research, product development, and product efficacy and safety testing.

NativeSkin® Tape Stripped Disrupted skin barrier model

NativeSkin® Tape Stripped


Disrupted skin barrier model

NativeSkin® Tape Stripped is a live human skin model with a mechanically impaired stratum corneum that reproduces controlled barrier disruption. It supports the evaluation of barrier-repair products, penetration, irritation and responses in compromised skin.

Compare Genoskin models

Genoskin

Different applications need different tissue characteristics. Use this as a starting point, or ask our team for a recommendation.

Need help choosing the right model for your research?
Tell us what you’re testing. A Genoskin scientist will help identify the appropriate model, configuration and experimental approach.

Get a model recommendation

How it works

Genoskin

From donated skin to reliable human data

Standardized production process for actionable data

Frequently asked questions

Which Genoskin model should I choose?

The appropriate model depends on your research objective:

  • HypoSkin®: intradermal and subcutaneous administration
  • NativeSkin®: topical efficacy, safety, penetration and skin-response studies
  • NativeSkin® Tape Stripped: disrupted-barrier and barrier-repair studies
  • WoundSkin®: wound healing, infection and wound-care research
  • HairSkin®: scalp, hair follicle and pilosebaceous-unit research
  • FacialSkin: facial skincare and treatment development
  • BreastSkin: breast, bust and décolleté research

What skin layers are preserved in the models?

All Genoskin’s models preserve the epidermis and dermis. HypoSkin® also includes the hypodermis, making it suitable for subcutaneous administration.

Are Genoskin models immunocompetent?

Yes. All models preserve resident immune cells within their native human tissue environment, enabling the assessment of inflammatory and immune-related responses.

Can several donors be included in a single order?

Yes. Including samples from multiple donors helps assess biological variability and increases the relevance of study results. Donor availability depends on the model, tissue source and required study timeline.

How is ex vivo human skin different from reconstructed skin models?

Ex vivo skin is real donated tissue kept alive outside the body, retaining the immune compartment, appendages and native architecture that reconstructed models cannot replicate.

Where does the human tissue come from?

Genoskin models are produced from human tissue collected following surgical procedures. Tissue is obtained with donor consent and in accordance with applicable ethical and regulatory requirements.

Can the models be customized based on donor characteristics?

Yes. Models can be selected according to donor characteristics such as gender, age range, and skin phototype, subject to tissue availability.

Are all models available for purchase?

Yes. Models are available as ready-to-use products on our online ordering platform. Availability, delivery regions and lead times may vary according to the model and donor tissue supply.

What is the delivery time and form of delivery? Can you ship to my location?

Once your models are produced, they are shipped on the same day, overnight through airfreight. For Asia-Pacific countries, the delivery can take up to 72 hours. We ship our products globally.

What does it cost?

Pricing depends on the model, configuration and volume. Tell us what you’re testing and we’ll send a quote. Get a quote.

Have more questions? Visit our FAQ page →

Need more than the tissue model?

Genoskin also designs and runs studies end to end, protocol to report. Injection site reactions, local tolerance, psoriasis research, vaccine immunoprofiling and topical efficacy. Most projects begin within two weeks of signature and complete in four to eight weeks.

Also available: human primary mast cells for allergy, immunotoxicity and mast cell-targeted research. Explore mast cells

Want more research like this in your inbox? Subscribe to our newsletter →